Literature DB >> 9574680

Detection of kanamycin-resistant Mycobacterium tuberculosis by identifying mutations in the 16S rRNA gene.

Y Suzuki1, C Katsukawa, A Tamaru, C Abe, M Makino, Y Mizuguchi, H Taniguchi.   

Abstract

In Mycobacterium smegmatis and a limited number of Mycobacterium tuberculosis strains, the involvement of alterations of the 16S rRNA gene (rrs) in resistance to kanamycin has been shown. To investigate the extent to which mutations in a specific region of the rrs gene and the kanamycin-resistant phenotype in clinically isolated M. tuberculosis strains were correlated, 43 kanamycin-resistant strains (MICs, > or =200 microg/ml), 71 kanamycin-susceptible strains, and 4 type strains were examined. The 300-bp DNA fragments carrying the rrs gene and the intervening sequence between the rrs gene and 23S rRNA (rrl) gene fragments were amplified by PCR and were subjected to PCR-based direct sequencing. By comparing the nucleotide sequences, substitutions were found in 29 of 43 (67.4%) kanamycin-resistant clinical isolates at positions 1400, 1401, and 1483 but in none of the 71 sensitive isolates or the 4 type strains. The most frequent substitution, from A to G, occurred at position 1400. A substitution from C to T at position 1401 was found once. Two clinical isolates carried the double mutation from C to A at position 1401 and from G to T at position 1483. In addition, we found that these mutants can be distinguished from wild-type strains by digestion with the restriction endonucleases TaiI and Tsp45I. Furthermore, we found that the genotypes of kanamycin-resistant strains can be discriminated from each other by digestion with a restriction endonuclease, BstUI or DdeI.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9574680      PMCID: PMC104803          DOI: 10.1128/JCM.36.5.1220-1225.1998

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

1.  Altered ribosomes in antibiotic-resistant mutants of Mycobacterium smegmatis.

Authors:  T Yamada; K Masuda; Y Mizuguchi; K Suga
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

2.  Characterization of the rpsL and rrs genes of streptomycin-resistant clinical isolates of Mycobacterium tuberculosis in Japan.

Authors:  C Katsukawa; A Tamaru; Y Miyata; C Abe; M Makino; Y Suzuki
Journal:  J Appl Microbiol       Date:  1997-11       Impact factor: 3.772

3.  Permeability barrier to rifampin in mycobacteria.

Authors:  J Hui; N Gordon; R Kajioka
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

4.  The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol.

Authors:  A E Belanger; G S Besra; M E Ford; K Mikusová; J T Belisle; P J Brennan; J M Inamine
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

5.  Genetic organization of Tn5.

Authors:  S J Rothstein; R A Jorgensen; J C Yin; Z Yong-di; R C Johnson; W S Reznikoff
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1981

6.  Mechanism of inhibition of translocation by kanamycin and viomycin: a comparative study with fusidic acid.

Authors:  M Misumi; N Tanaka
Journal:  Biochem Biophys Res Commun       Date:  1980-01-29       Impact factor: 3.575

7.  Molecular analysis of kanamycin and viomycin resistance in Mycobacterium smegmatis by use of the conjugation system.

Authors:  H Taniguchi; B Chang; C Abe; Y Nikaido; Y Mizuguchi; S I Yoshida
Journal:  J Bacteriol       Date:  1997-08       Impact factor: 3.490

8.  Overexpression of the D-alanine racemase gene confers resistance to D-cycloserine in Mycobacterium smegmatis.

Authors:  N E Cáceres; N B Harris; J F Wellehan; Z Feng; V Kapur; R G Barletta
Journal:  J Bacteriol       Date:  1997-08       Impact factor: 3.490

9.  Streptomycin resistance in mycobacteria.

Authors:  N Honoré; S T Cole
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

10.  Coresistance to neomycin and kanamycin by mutations in an Escherichia coli locus that affects ribosomes.

Authors:  D Apirion; D Schlessinger
Journal:  J Bacteriol       Date:  1968-09       Impact factor: 3.490

View more
  60 in total

1.  Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay.

Authors:  K Hirano; C Abe; M Takahashi
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

2.  Kanamycin susceptibility testing of Mycobacterium tuberculosis using Mycobacterium Growth Indicator Tube and a colorimetric method.

Authors:  I Bastian; L Rigouts; J C Palomino; F Portaels
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  A mutation in the decoding center of Thermus thermophilus 16S rRNA suggests a novel mechanism of streptomycin resistance.

Authors:  Steven T Gregory; Jennifer F Carr; Albert E Dahlberg
Journal:  J Bacteriol       Date:  2005-03       Impact factor: 3.490

4.  Mutation detection and accurate diagnosis of extensively drug-resistant tuberculosis: report from a tertiary care center in India.

Authors:  Kanchan Ajbani; Camilla Rodrigues; Shubhada Shenai; Ajita Mehta
Journal:  J Clin Microbiol       Date:  2011-02-02       Impact factor: 5.948

5.  Mutations conferring aminoglycoside and spectinomycin resistance in Borrelia burgdorferi.

Authors:  Daniel Criswell; Virginia L Tobiason; J Stephen Lodmell; D Scott Samuels
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

Review 6.  A balancing act: efflux/influx in mycobacterial drug resistance.

Authors:  G E Louw; R M Warren; N C Gey van Pittius; C R E McEvoy; P D Van Helden; T C Victor
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

7.  Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment.

Authors:  Silke Feuerriegel; Helen S Cox; Nana Zarkua; Hamraev A Karimovich; Kai Braker; Sabine Rüsch-Gerdes; Stefan Niemann
Journal:  Antimicrob Agents Chemother       Date:  2009-05-26       Impact factor: 5.191

8.  Aminoglycoside cross-resistance in Mycobacterium tuberculosis due to mutations in the 5' untranslated region of whiB7.

Authors:  Analise Z Reeves; Patricia J Campbell; Razvan Sultana; Seidu Malik; Megan Murray; Bonnie B Plikaytis; Thomas M Shinnick; James E Posey
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191

9.  Molecular genetics of Mycobacterium tuberculosis resistant to aminoglycosides and cyclic peptide capreomycin antibiotics in Korea.

Authors:  Hum Nath Jnawali; Heekyung Yoo; Sungweon Ryoo; Kwang-Jun Lee; Bum-Joon Kim; Won-Jung Koh; Chang-Ki Kim; Hee-Jin Kim; Young Kil Park
Journal:  World J Microbiol Biotechnol       Date:  2013-01-18       Impact factor: 3.312

10.  Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis.

Authors:  Yingda L Xie; Soumitesh Chakravorty; Derek T Armstrong; Sandra L Hall; Laura E Via; Taeksun Song; Xing Yuan; Xiaoying Mo; Hong Zhu; Peng Xu; Qian Gao; Myungsun Lee; Jongseok Lee; Laura E Smith; Ray Y Chen; Joon Sung Joh; YoungSoo Cho; Xin Liu; Xianglin Ruan; Lili Liang; Nila Dharan; Sang-Nae Cho; Clifton E Barry; Jerrold J Ellner; Susan E Dorman; David Alland
Journal:  N Engl J Med       Date:  2017-09-14       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.